Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Leder, K; Weller, PF; Wilson, ME
   Travel vaccines and elderly persons: Review of vaccines available in the United States
   CLINICAL INFECTIOUS DISEASES
   
   K. Leder et al., "Travel vaccines and elderly persons: Review of vaccines available in the United States", CLIN INF D, 33(9), 2001, pp. 1553-1566
2. Dennehy, PH
   Active immunization in the United States: Developments over the past decade
   CLINICAL MICROBIOLOGY REVIEWS
   
   P.H. Dennehy, "Active immunization in the United States: Developments over the past decade", CLIN MICROB, 14(4), 2001, pp. 872-908
3. Wilson, ME
   Travel-related vaccines
   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
   
   M.E. Wilson, "Travel-related vaccines", INF DIS CL, 15(1), 2001, pp. 231
4. Lopez, EL; Xifro, MD; Torrado, LE; De Rosa, MF; Gomez, R; Dumas, R; Wood, SC; Contrini, MP
   Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children
   PEDIATRIC INFECTIOUS DISEASE JOURNAL
   
   E.L. Lopez et al., "Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children", PEDIAT INF, 20(1), 2001, pp. 48-52
5. Lesprit, P
   Vaccination and antiinfectious protection in patients with acquired or congenital immunodeficiency
   PRESSE MEDICALE
   
   P. Lesprit, "Vaccination and antiinfectious protection in patients with acquired or congenital immunodeficiency", PRESSE MED, 30(15), 2001, pp. 759-766
6. Joines, RW; Blatter, M; Abraham, B; Xie, F; De Clercq, N; Baine, Y; Reisinger, KS; Kuhnen, A
   A prospective, randomized, comparative US trial of a combination hepatitisA and B vaccine (Twinrix (R)) with corresponding monovalent vaccines (Havrix (R) and Engerix-B (R)) in adults
   VACCINE
   
   R.W. Joines et al., "A prospective, randomized, comparative US trial of a combination hepatitisA and B vaccine (Twinrix (R)) with corresponding monovalent vaccines (Havrix (R) and Engerix-B (R)) in adults", VACCINE, 19(32), 2001, pp. 4710-4719
7. Moingeon, P; Haensler, J; Lindberg, A
   Towards the rational design of Th1 adjuvants
   VACCINE
   
   P. Moingeon et al., "Towards the rational design of Th1 adjuvants", VACCINE, 19(31), 2001, pp. 4363-4372
8. Clarke, P; Kitchin, N; Souverbie, F
   A randomised comparison of two inactivated hepatitis A vaccines, Avaxim (TM) and Vaqta (TM), given as a booster to subjects primed with Avaxim (TM)
   VACCINE
   
   P. Clarke et al., "A randomised comparison of two inactivated hepatitis A vaccines, Avaxim (TM) and Vaqta (TM), given as a booster to subjects primed with Avaxim (TM)", VACCINE, 19(31), 2001, pp. 4429-4433
9. Linglof, T; van Hattum, J; Kaplan, KM; Corrigan, J; Duval, I; Jensen, E; Kuter, B
   An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity
   VACCINE
   
   T. Linglof et al., "An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity", VACCINE, 19(28-29), 2001, pp. 3968-3971
10. Stroffolini, T; Mele, A; Sagliocca, L
    Vaccination policy against hepatitis A in Italy
    VACCINE
    
    T. Stroffolini et al., "Vaccination policy against hepatitis A in Italy", VACCINE, 19(17-19), 2001, pp. 2404-2406
11. Van Damme, P; Van der Wielen, M
    Combining hepatitis A and B vaccination in children and adolescents
    VACCINE
    
    P. Van Damme e M. Van der Wielen, "Combining hepatitis A and B vaccination in children and adolescents", VACCINE, 19(17-19), 2001, pp. 2407-2412
12. Campbell, AL; Bryant, KA
    Routine childhood immunizations
    PRIMARY CARE
    
    A.L. Campbell e K.A. Bryant, "Routine childhood immunizations", PRIM CARE, 28(4), 2001, pp. 713
13. Arguedas, MR; Fallon, MB
    Prevention in liver disease
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    
    M.R. Arguedas e M.B. Fallon, "Prevention in liver disease", AM J MED SC, 321(2), 2001, pp. 145-151
14. Edwards, KM; Gruber, WC
    Immunization in hematopoietic cell transplantation
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE
    
    K.M. Edwards e W.C. Gruber, "Immunization in hematopoietic cell transplantation", PEDIAT PATH, 19(2-3), 2000, pp. 133-148
15. Hilleman, MR
    Vaccines in historic evolution and perspective - A narrative of vaccine discoveries
    JOURNAL OF HUMAN VIROLOGY
    
    M.R. Hilleman, "Vaccines in historic evolution and perspective - A narrative of vaccine discoveries", J HUMAN VIR, 3(2), 2000, pp. 63-76
16. Lee, SD
    Asian perspectives on viral hepatitis A
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    
    S.D. Lee, "Asian perspectives on viral hepatitis A", J GASTR HEP, 15, 2000, pp. G94-G99
17. Sohn, YM; Rho, HO; Park, MS; Park, JH; Choi, BY; Ki, M; Jang, WI
    The changing epidemiology of hepatitis A in children and the considerationof active immunization in Korea
    YONSEI MEDICAL JOURNAL
    
    Y.M. Sohn et al., "The changing epidemiology of hepatitis A in children and the considerationof active immunization in Korea", YONSEI MED, 41(1), 2000, pp. 34-39
18. Hu, YZ; Tan, SG; Shao, CW; Jin, WX; Ji, QY; He, JH; Chen, HB; Yan, J
    Safety and immunogenicity of lyophilized, live attenuated hepatitis A vaccine in non-human primate model
    CHINESE MEDICAL JOURNAL
    
    Y.Z. Hu et al., "Safety and immunogenicity of lyophilized, live attenuated hepatitis A vaccine in non-human primate model", CHIN MED J, 113(4), 2000, pp. 332-335
19. Greub, G; Genton, B; Safary, A; Thoelen, S; Frei, PC
    Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix (TM)
    VACCINE
    
    G. Greub et al., "Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix (TM)", VACCINE, 19(9-10), 2000, pp. 1113-1117
20. Bryan, JP; Henry, CH; Hoffman, AG; South-Paul, JE; Smith, JA; Cruess, D; Spieker, JMR; de Medina, M
    Randomized, cross-over, controlled comparison of two inactivated hepatitisA vaccines
    VACCINE
    
    J.P. Bryan et al., "Randomized, cross-over, controlled comparison of two inactivated hepatitisA vaccines", VACCINE, 19(7-8), 2000, pp. 743-750
21. Hilleman, MR
    Vaccines in historic evolution and perspective: a narrative of vaccine discoveries
    VACCINE
    
    M.R. Hilleman, "Vaccines in historic evolution and perspective: a narrative of vaccine discoveries", VACCINE, 18(15), 2000, pp. 1436-1447
22. Ortiz, A; Cajal, Y; Haro, I; Reig, F; Alsina, MA
    Fluorescence study on the interaction of a multiple antigenic peptide fromhepatitis A virus with lipid vesicles
    BIOPOLYMERS
    
    A. Ortiz et al., "Fluorescence study on the interaction of a multiple antigenic peptide fromhepatitis A virus with lipid vesicles", BIOPOLYMERS, 53(6), 2000, pp. 455-466
23. Bell, BP
    Hepatitis A and hepatitis B vaccination of patients with chronic liver disease
    ACTA GASTRO-ENTEROLOGICA BELGICA
    
    B.P. Bell, "Hepatitis A and hepatitis B vaccination of patients with chronic liver disease", ACT GASTR B, 63(4), 2000, pp. 359-363
24. Riley, TR; Smith, JP
    Preventive care in chronic liver disease
    JOURNAL OF GENERAL INTERNAL MEDICINE
    
    T.R. Riley e J.P. Smith, "Preventive care in chronic liver disease", J GEN INT M, 14(11), 1999, pp. 699-704
25. LU MY; CHANG MH; TSAI KS; CHEN DS
    HEPATITIS-A VACCINE IN HEALTHY-ADULTS - A COMPARISON OF IMMUNOGENICITY AND REACTOGENICITY BETWEEN 2-DOSE AND 3-DOSE REGIMENS
    Vaccine
    
    M.Y. Lu et al., "HEPATITIS-A VACCINE IN HEALTHY-ADULTS - A COMPARISON OF IMMUNOGENICITY AND REACTOGENICITY BETWEEN 2-DOSE AND 3-DOSE REGIMENS", Vaccine, 17(1), 1999, pp. 26-30
26. de Febres, OC; de Petrola, MC; de Escalona, LC; Naveda, O; Naveda, M; Estopinan, M; Bordones, G; Zambrano, B; Garcia, A; Dumas, R
    Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children
    VACCINE
    
    O.C. de Febres et al., "Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children", VACCINE, 18(7-8), 1999, pp. 656-664
27. Piazza, M; Safary, A; Vegnente, A; Soncini, R; Pensati, P; Sardo, M; Orlando, R; Tosone, G; Picciotto, L
    Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme
    VACCINE
    
    M. Piazza et al., "Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme", VACCINE, 17(6), 1999, pp. 585-588
28. Chan, CY; Lee, SD; Yu, MI; Wang, YJ; Chang, FY; Lo, KJ
    Long-term follow-up of hepatitis A vaccination in children
    VACCINE
    
    C.Y. Chan et al., "Long-term follow-up of hepatitis A vaccination in children", VACCINE, 17(4), 1999, pp. 369-372
29. Braconier, JH; Wennerholm, S; Norrby, SR
    Comparative immunogenicity and tolerance of Vaqta (TM) and Havrix (TM)
    VACCINE
    
    J.H. Braconier et al., "Comparative immunogenicity and tolerance of Vaqta (TM) and Havrix (TM)", VACCINE, 17(17), 1999, pp. 2181-2184
30. Dagan, R; Greenberg, D; Goldenbertg-Gehtman, P; Vidor, E; Briantais, P; Pinsk, V; Athias, O; Dumas, R
    Safety and immunogenicity of a new formulation of an inactivated hepatitisA vaccine
    VACCINE
    
    R. Dagan et al., "Safety and immunogenicity of a new formulation of an inactivated hepatitisA vaccine", VACCINE, 17(15-16), 1999, pp. 1919-1925
31. Gluck, R
    Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs)
    VACCINE
    
    R. Gluck, "Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs)", VACCINE, 17(13-14), 1999, pp. 1782-1787
32. Walter, EB; Hornick, RB; Poland, GA; Tucker, R; Bland, CL; Clements, DA; Rhamstine, CC; Jacobson, RM; Brown, L; Gress, JO; Harris, KE; Wiens, BL; Nalin, DR
    Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults
    VACCINE
    
    E.B. Walter et al., "Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults", VACCINE, 17(11-12), 1999, pp. 1468-1473
33. Domart, M; Mlika-Cabanne, N; Henzel, D; Pouliquen, A; Florentin, A; Marande, JL; Xerri, B; Aufrere, A; Larouze, B
    Hepatitis A among health workers in Paris hospitals
    JOURNAL OF MEDICAL VIROLOGY
    
    M. Domart et al., "Hepatitis A among health workers in Paris hospitals", J MED VIROL, 58(4), 1999, pp. 321-324
34. REUTTER J; BART PA; FRANCIOLI P; SAFARY A; FREI PC
    PRODUCTION OF ANTIBODY TO HEPATITIS-A VIRUS AND HEPATITIS-B SURFACE-ANTIGEN MEASURED AFTER COMBINED HEPATITIS-A HEPATITIS-B VACCINATION IN 242 ADULT VOLUNTEERS/
    Journal of viral hepatitis
    
    J. Reutter et al., "PRODUCTION OF ANTIBODY TO HEPATITIS-A VIRUS AND HEPATITIS-B SURFACE-ANTIGEN MEASURED AFTER COMBINED HEPATITIS-A HEPATITIS-B VACCINATION IN 242 ADULT VOLUNTEERS/", Journal of viral hepatitis, 5(3), 1998, pp. 205-211
35. HILLEMAN MR
    6 DECADES OF VACCINE DEVELOPMENT - A PERSONAL HISTORY
    Nature medicine
    
    M.R. Hilleman, "6 DECADES OF VACCINE DEVELOPMENT - A PERSONAL HISTORY", Nature medicine, 4(5), 1998, pp. 507-514
36. SCHWARTZ E; RAVEH D
    THE PREVALENCE OF HEPATITIS-A ANTIBODIES AMONG ISRAELI TRAVELERS AND THE ECONOMIC-FEASIBILITY OF SCREENING BEFORE VACCINATION
    International journal of epidemiology
    
    E. Schwartz e D. Raveh, "THE PREVALENCE OF HEPATITIS-A ANTIBODIES AMONG ISRAELI TRAVELERS AND THE ECONOMIC-FEASIBILITY OF SCREENING BEFORE VACCINATION", International journal of epidemiology, 27(1), 1998, pp. 118-120
37. FAN PC; CHANG MH; LEE PI; SAFARY A; LEE CY
    FOLLOW-UP IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VIRUS-VACCINE IN HEALTHY-CHILDREN - RESULTS AFTER 5 YEARS
    Vaccine
    
    P.C. Fan et al., "FOLLOW-UP IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VIRUS-VACCINE IN HEALTHY-CHILDREN - RESULTS AFTER 5 YEARS", Vaccine, 16(2-3), 1998, pp. 232-235
38. Saliou, P
    Vaccines for the prevention of diseases transmitted by the feco-oral route.
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE
    
    P. Saliou, "Vaccines for the prevention of diseases transmitted by the feco-oral route.", B S PATH EX, 91(5BIS), 1998, pp. 445-449
39. WIEDERMANN G; KUNDI M; AMBROSCH F
    ESTIMATED PERSISTENCE OF ANTI-HAV ANTIBODIES AFTER SINGLE-DOSE AND BOOSTER HEPATITIS-A VACCINATION (0-6 SCHEDULE)
    Acta Tropica
    
    G. Wiedermann et al., "ESTIMATED PERSISTENCE OF ANTI-HAV ANTIBODIES AFTER SINGLE-DOSE AND BOOSTER HEPATITIS-A VACCINATION (0-6 SCHEDULE)", Acta Tropica, 69(2), 1998, pp. 121-125
40. BEEKMANN SE; DOEBBELING BN
    FRONTIERS OF OCCUPATIONAL-HEALTH - NEW VACCINES, NEW PROPHYLACTIC REGIMENS, AND MANAGEMENT OF THE HIV-INFECTED WORKER
    Infectious disease clinics of North America
    
    S.E. Beekmann e B.N. Doebbeling, "FRONTIERS OF OCCUPATIONAL-HEALTH - NEW VACCINES, NEW PROPHYLACTIC REGIMENS, AND MANAGEMENT OF THE HIV-INFECTED WORKER", Infectious disease clinics of North America, 11(2), 1997, pp. 313
41. TOERNER JG; MATHEWS WC
    GUIDELINES FOR IMMUNIZATIONS IN HIV-INFECTED PATIENTS
    Immunology and allergy clinics of North America
    
    J.G. Toerner e W.C. Mathews, "GUIDELINES FOR IMMUNIZATIONS IN HIV-INFECTED PATIENTS", Immunology and allergy clinics of North America, 17(2), 1997, pp. 195
42. FUJIYAMA S; ODOH K; TANAKA M; KURAMOTO I; TOMITA K
    EVALUATION OF THE TIMING OF THE BOOSTER INJECTION AFTER A PRIMARY VACCINATION AGAINST HEPATITIS-A
    Journal of gastroenterology and hepatology
    
    S. Fujiyama et al., "EVALUATION OF THE TIMING OF THE BOOSTER INJECTION AFTER A PRIMARY VACCINATION AGAINST HEPATITIS-A", Journal of gastroenterology and hepatology, 12(2), 1997, pp. 172-175
43. DUMAS R; FORRAT R; LANG J; FARINELLI T; LOUTAN L
    SAFETY AND IMMUNOGENICITY OF A NEW INACTIVATED HEPATITIS-A VACCINE INCONCURRENT ADMINISTRATION WITH A TYPHOID-FEVER VACCINE OR A TYPHOID-FEVER PLUS YELLOW-FEVER VACCINE
    Advances in therapy
    
    R. Dumas et al., "SAFETY AND IMMUNOGENICITY OF A NEW INACTIVATED HEPATITIS-A VACCINE INCONCURRENT ADMINISTRATION WITH A TYPHOID-FEVER VACCINE OR A TYPHOID-FEVER PLUS YELLOW-FEVER VACCINE", Advances in therapy, 14(4), 1997, pp. 160-167
44. ZUCKERMAN J; PEYRON F; WALLON M; GAY F; DELOLME H; BRIANTAIS P; VIDOR E
    COMPARISON OF THE SAFETY AND IMMUNOGENICITY OF 2 INACTIVATED HEPATITIS-A VACCINES
    Advances in therapy
    
    J. Zuckerman et al., "COMPARISON OF THE SAFETY AND IMMUNOGENICITY OF 2 INACTIVATED HEPATITIS-A VACCINES", Advances in therapy, 14(3), 1997, pp. 116-124
45. MAIWALD H; JILG W; BOCK HL; LOSCHER T; VONSONNENBURG F
    LONG-TERM PERSISTENCE OF ANTI-HAV ANTIBODIES FOLLOWING ACTIVE IMMUNIZATION WITH HEPATITIS-A VACCINE
    Vaccine
    
    H. Maiwald et al., "LONG-TERM PERSISTENCE OF ANTI-HAV ANTIBODIES FOLLOWING ACTIVE IMMUNIZATION WITH HEPATITIS-A VACCINE", Vaccine, 15(4), 1997, pp. 346-348
46. AMBROSCH F; WIEDERMANN G; JONAS S; ALTHAUS B; FINKEL B; GLUCK R; HERZOG C
    IMMUNOGENICITY AND PROTECTIVITY OF A NEW LIPOSOMAL HEPATITIS-A VACCINE
    Vaccine
    
    F. Ambrosch et al., "IMMUNOGENICITY AND PROTECTIVITY OF A NEW LIPOSOMAL HEPATITIS-A VACCINE", Vaccine, 15(11), 1997, pp. 1209-1213
47. TOTOS G; GIZARIS V; PAPAEVANGELOU G
    HEPATITIS-A VACCINE - PERSISTENCE OF ANTIBODIES 5 YEARS AFTER THE FIRST VACCINATION
    Vaccine
    
    G. Totos et al., "HEPATITIS-A VACCINE - PERSISTENCE OF ANTIBODIES 5 YEARS AFTER THE FIRST VACCINATION", Vaccine, 15(11), 1997, pp. 1252-1253
48. REUMAN PD; KUBILIS P; HURNI W; BROWN L; NALIN D
    THE EFFECT OF AGE AND WEIGHT ON THE RESPONSE TO FORMALIN-INACTIVATED,ALUM-ADJUVANTED HEPATITIS-A VACCINE IN HEALTHY-ADULTS
    Vaccine
    
    P.D. Reuman et al., "THE EFFECT OF AGE AND WEIGHT ON THE RESPONSE TO FORMALIN-INACTIVATED,ALUM-ADJUVANTED HEPATITIS-A VACCINE IN HEALTHY-ADULTS", Vaccine, 15(10), 1997, pp. 1157-1161
49. LEE SD; CHAN CY; YU MI; WANG YJ; CHANG FY; LO KJ; SAFARY A
    SAFETY AND IMMUNOGENICITY OF INACTIVATED HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE
    Journal of medical virology
    
    S.D. Lee et al., "SAFETY AND IMMUNOGENICITY OF INACTIVATED HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE", Journal of medical virology, 52(2), 1997, pp. 215-218
50. HAGEN AJ; OLIVER CN; SITRIN RD
    OPTIMIZATION AND SCALE-UP OF SOLVENT-EXTRACTION IN PURIFICATION OF HEPATITIS-A VIRUS (VAQTA(R))
    Biotechnology and bioengineering
    
    A.J. Hagen et al., "OPTIMIZATION AND SCALE-UP OF SOLVENT-EXTRACTION IN PURIFICATION OF HEPATITIS-A VIRUS (VAQTA(R))", Biotechnology and bioengineering, 56(1), 1997, pp. 83-88
51. SABBAJ S; KIYONO H; MCGHEE JR
    MUCOSAL IMMUNIZATION FOR ENTERIC DISEASES - CURRENT PRACTICE AND FUTURE-PROSPECTS
    Biodrugs
    
    S. Sabbaj et al., "MUCOSAL IMMUNIZATION FOR ENTERIC DISEASES - CURRENT PRACTICE AND FUTURE-PROSPECTS", Biodrugs, 7(2), 1997, pp. 134-157
52. ZUCKERMAN JN; MOORE S; SMITH J; TYRRELL H; BAXTER A; LEE CA
    A STUDY TO ASSESS THE IMMUNOGENICITY, REACTOGENICITY AND SAFETY OF HEPATITIS-A VACCINE ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH CONGENITAL COAGULATION DISORDERS
    Haemophilia
    
    J.N. Zuckerman et al., "A STUDY TO ASSESS THE IMMUNOGENICITY, REACTOGENICITY AND SAFETY OF HEPATITIS-A VACCINE ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH CONGENITAL COAGULATION DISORDERS", Haemophilia, 2(4), 1996, pp. 235-239
53. LO YC; LEE SS; WONG KH; LIM WL
    INACTIVATED HEPATITIS-A VACCINE IN HEALTHY CHINESE ADULTS
    Journal of internal medicine
    
    Y.C. Lo et al., "INACTIVATED HEPATITIS-A VACCINE IN HEALTHY CHINESE ADULTS", Journal of internal medicine, 239(2), 1996, pp. 173-176
54. NETTLEMAN MD
    PREPARING THE INTERNATIONAL TRAVELER
    Gastroenterology clinics of North America
    
    M.D. Nettleman, "PREPARING THE INTERNATIONAL TRAVELER", Gastroenterology clinics of North America, 25(3), 1996, pp. 451
55. RAJAN E; ALBLOUSHI S; OFARRELL B; SHATTOCK A; COURTNEY MG; SAFARY A; FIELDING JF
    2-YEAR OLD HEPATITIS-A VACCINE IS AS GOOD AS NEW
    Vaccine
    
    E. Rajan et al., "2-YEAR OLD HEPATITIS-A VACCINE IS AS GOOD AS NEW", Vaccine, 14(15), 1996, pp. 1439-1441
56. LANGER BCA; LOVESTAD A; FROSNER GG
    HIGH IMMUNOGENICITY AND GOOD TOLERABILITY OF A NEW HEPATITIS-A VACCINE CANDIDATE
    Vaccine
    
    B.C.A. Langer et al., "HIGH IMMUNOGENICITY AND GOOD TOLERABILITY OF A NEW HEPATITIS-A VACCINE CANDIDATE", Vaccine, 14(12), 1996, pp. 1089-1091
57. FISCH A; CADILHAC P; VIDOR E; PRAZUCK T; DUBLANCHET A; LAFAIX C
    IMMUNOGENICITY AND SAFETY OF A NEW INACTIVATED HEPATITIS-A VACCINE - A CLINICAL-TRIAL WITH COMPARISON OF ADMINISTRATION ROUTE
    Vaccine
    
    A. Fisch et al., "IMMUNOGENICITY AND SAFETY OF A NEW INACTIVATED HEPATITIS-A VACCINE - A CLINICAL-TRIAL WITH COMPARISON OF ADMINISTRATION ROUTE", Vaccine, 14(12), 1996, pp. 1132-1136
58. GIL A; GONZALEZ A; DALRE R; CALERO R
    INTERFERENCE ASSESSMENT OF YELLOW-FEVER VACCINE WITH THE IMMUNE-RESPONSE TO A SINGLE-DOSE INACTIVATED HEPATITIS-A VACCINE (1440-ELU) - A CONTROLLED-STUDY IN ADULTS
    Vaccine
    
    A. Gil et al., "INTERFERENCE ASSESSMENT OF YELLOW-FEVER VACCINE WITH THE IMMUNE-RESPONSE TO A SINGLE-DOSE INACTIVATED HEPATITIS-A VACCINE (1440-ELU) - A CONTROLLED-STUDY IN ADULTS", Vaccine, 14(11), 1996, pp. 1028-1030
59. TILZEY AJ; PALMER SJ; HARRINGTON C; ODOHERTY MJ
    HEPATITIS-A VACCINE RESPONSES IN HIV-POSITIVE PERSONS WITH HEMOPHILIA
    Vaccine
    
    A.J. Tilzey et al., "HEPATITIS-A VACCINE RESPONSES IN HIV-POSITIVE PERSONS WITH HEMOPHILIA", Vaccine, 14(11), 1996, pp. 1039-1041
60. ZUCKERMAN JN; POWELL L; LEQUIN RM; ZUCKERMAN AJ
    DETERMINATION OF HEPATITIS-A ANTIBODY-RESPONSE TO VACCINATION BY AN ENZYME-IMMUNOASSAY
    Journal of virological methods
    
    J.N. Zuckerman et al., "DETERMINATION OF HEPATITIS-A ANTIBODY-RESPONSE TO VACCINATION BY AN ENZYME-IMMUNOASSAY", Journal of virological methods, 56(1), 1996, pp. 27-31
61. HODES DS
    CHILDHOOD IMMUNIZATIONS - 1996
    The Mount Sinai journal of medicine
    
    D.S. Hodes, "CHILDHOOD IMMUNIZATIONS - 1996", The Mount Sinai journal of medicine, 63(5-6), 1996, pp. 413-419
62. GARDNER P; EICKHOFF T; POLAND GA; GROSS P; GRIFFIN M; LAFORCE M; SCHAFFNER W; STRIKAS R
    ADULT IMMUNIZATIONS
    Annals of internal medicine
    
    P. Gardner et al., "ADULT IMMUNIZATIONS", Annals of internal medicine, 124(1), 1996, pp. 35-40
63. GOILAV C; ZUCKERMAN J; LAFRENZ M; VIDOR E; LAUWERS S; RATHEAU C; BENICHOU G; ZUCKERMAN A
    IMMUNOGENICITY AND SAFETY OF A NEW INACTIVATED HEPATITIS-A VACCINE INA COMPARATIVE-STUDY
    Journal of medical virology
    
    C. Goilav et al., "IMMUNOGENICITY AND SAFETY OF A NEW INACTIVATED HEPATITIS-A VACCINE INA COMPARATIVE-STUDY", Journal of medical virology, 46(3), 1995, pp. 287-292
64. KURAMOTO I; FUJIYAMA S; MATSUSHITA K; SATO T
    IMMUNE-RESPONSE AFTER HEPATITIS-A VACCINATION IN HEMODIALYSIS-PATIENTS - COMPARISON WITH HEPATITIS-B VACCINATION
    Journal of gastroenterology and hepatology
    
    I. Kuramoto et al., "IMMUNE-RESPONSE AFTER HEPATITIS-A VACCINATION IN HEMODIALYSIS-PATIENTS - COMPARISON WITH HEPATITIS-B VACCINATION", Journal of gastroenterology and hepatology, 9(3), 1994, pp. 228-231
65. BRINDLE RJ; MORRIS CA; BERGER R; KURTZ JB
    INADEQUATE RESPONSE TO INTRADERMAL HEPATITIS-A VACCINE
    Vaccine
    
    R.J. Brindle et al., "INADEQUATE RESPONSE TO INTRADERMAL HEPATITIS-A VACCINE", Vaccine, 12(6), 1994, pp. 483-484
66. FUJIYAMA S; ODOH K; KURAMOTO I; MIZUNO K; TSURUSAKI R; SATO T
    CURRENT SEROEPIDEMIOLOGICAL STATUS OF HEPATITIS-A WITH A COMPARISON OF ANTIBODY-TITERS AFTER INFECTION AND VACCINATION
    Journal of hepatology
    
    S. Fujiyama et al., "CURRENT SEROEPIDEMIOLOGICAL STATUS OF HEPATITIS-A WITH A COMPARISON OF ANTIBODY-TITERS AFTER INFECTION AND VACCINATION", Journal of hepatology, 21(4), 1994, pp. 641-645
67. KURAMOTO I; FUJIYAMA S; ODOH K; MIZUNO K; SATO T
    LONG-TERM FOLLOW-UP OF ANTIBODY-TITERS AFTER HEPATITIS-A VACCINATION
    HEPATOLOGY RESEARCH
    
    I. Kuramoto et al., "LONG-TERM FOLLOW-UP OF ANTIBODY-TITERS AFTER HEPATITIS-A VACCINATION", HEPATOLOGY RESEARCH, 1(4), 1993, pp. 194-199
68. HORNG YC; CHANG MH; LEE CY; SAFARY A; ANDRE FE; CHEN DS
    SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN HEALTHY-CHILDREN
    The Pediatric infectious disease journal
    
    Y.C. Horng et al., "SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN HEALTHY-CHILDREN", The Pediatric infectious disease journal, 12(5), 1993, pp. 359-362
69. HORNG YC; CHANG MH; LEE CY; SAFARY A; ANDRE FE; CHEN DS
    SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN HEALTHY ADULT VOLUNTEERS
    Journal of gastroenterology and hepatology
    
    Y.C. Horng et al., "SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN HEALTHY ADULT VOLUNTEERS", Journal of gastroenterology and hepatology, 8(4), 1993, pp. 338-341
70. SHOUVAL D; ASHUR Y; ADLER R; LEWIS JA; MILLER W; KUTER B; BROWN L; NALIN DR
    SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE - EFFECTS OF SINGLE AND BOOSTER INJECTIONS, AND COMPARISON TO ADMINISTRATION OF IMMUNE GLOBULIN
    Journal of hepatology
    
    D. Shouval et al., "SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE - EFFECTS OF SINGLE AND BOOSTER INJECTIONS, AND COMPARISON TO ADMINISTRATION OF IMMUNE GLOBULIN", Journal of hepatology, 18, 1993, pp. 190000032-190000037
71. JILG W; BITTNER R; SCHATZL H; RASSHOFER R; SCHMIDT M; DEINHARDT F
    THE IMMUNE-RESPONSE TO DIFFERENT DOSES OF INACTIVATED HEPATITIS-A VACCINE
    Journal of hepatology
    
    W. Jilg et al., "THE IMMUNE-RESPONSE TO DIFFERENT DOSES OF INACTIVATED HEPATITIS-A VACCINE", Journal of hepatology, 18, 1993, pp. 190000038-190000040
72. PAPAEVANGELOU G; TOTOS G; ROUMELIOTOU A; SAFARY A
    HEPATITIS-A VACCINATION IN GREEK MILITARY RECRUITS
    Journal of medical virology
    
    G. Papaevangelou et al., "HEPATITIS-A VACCINATION IN GREEK MILITARY RECRUITS", Journal of medical virology, 40(1), 1993, pp. 1-4